Under construction – not a live service
Sign in
Taking peopleNo phase

BRAVE Program for Safety and Violence Risk in Early Psychosis

Tests a talking therapy called BRAVE in young adults with early psychosis.

Plain-language title generated from the registry record
Registry title: BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis

Key facts

Where
Washington D.C., United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 16 and 30 years old?

Source: NCT07417904, who can take part

Where in United States

  • Howard University HospitalWashington D.C., United StatesNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Howard University
Trial code
NCT07417904
Record updated
29 July 2026
Original description
This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.Read full original descriptionShow less

Young Adults and Violent Behavior During Early Psychosis (Aim 3)

This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.

Inclusion: Young adults aged 16-30 years; Diagnosis of early psychosis; Currently receiving outpatient care through an early psychosis clinic; Psychiatrically stable and deemed appropriate for participation by a treating clinician; Able and willing to provide informed consent.

Exclusion: History of antisocial behavior, as assessed at baseline; Unable to provide informed consent; Not fluent in English; Immediate risk requiring a higher level of care.

ClinicalTrials.gov NCT07417904